ArticleCureus2022

Adverse Drug Reaction Monitoring in Multidrug-Resistant Tuberculosis Patients Receiving Bedaquiline and Delamanid-Based Regimen.

Elisha Paikray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.